A detailed history of Two Sigma Investments, LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 208,239 shares of KURA stock, worth $2.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
208,239
Previous 272,274 23.52%
Holding current value
$2.33 Million
Previous $5.61 Million 27.43%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.57 - $23.23 $1.19 Million - $1.49 Million
-64,035 Reduced 23.52%
208,239 $4.07 Million
Q2 2024

Aug 14, 2024

BUY
$17.53 - $22.98 $1.66 Million - $2.17 Million
94,624 Added 53.26%
272,274 $5.61 Million
Q1 2024

May 15, 2024

BUY
$13.42 - $23.53 $2.38 Million - $4.18 Million
177,650 New
177,650 $3.79 Million
Q3 2022

Nov 14, 2022

BUY
$12.01 - $19.45 $1.96 Million - $3.17 Million
163,239 Added 177.63%
255,139 $3.49 Million
Q2 2022

Aug 15, 2022

SELL
$10.71 - $18.33 $582,334 - $996,657
-54,373 Reduced 37.17%
91,900 $1.69 Million
Q1 2022

May 16, 2022

SELL
$11.78 - $16.98 $4.2 Million - $6.05 Million
-356,554 Reduced 70.91%
146,273 $2.35 Million
Q4 2021

Feb 14, 2022

BUY
$12.22 - $19.57 $1.08 Million - $1.74 Million
88,672 Added 21.41%
502,827 $7.04 Million
Q3 2021

Nov 15, 2021

SELL
$15.42 - $21.72 $5.74 Million - $8.09 Million
-372,272 Reduced 47.34%
414,155 $7.76 Million
Q2 2021

Aug 16, 2021

BUY
$20.85 - $29.88 $3.71 Million - $5.32 Million
178,144 Added 29.29%
786,427 $16.4 Million
Q1 2021

May 17, 2021

BUY
$24.75 - $39.14 $603,083 - $953,724
24,367 Added 4.17%
608,283 $17.2 Million
Q4 2020

Feb 16, 2021

BUY
$29.0 - $41.62 $16.5 Million - $23.7 Million
568,716 Added 3741.55%
583,916 $19.1 Million
Q3 2020

Nov 16, 2020

SELL
$16.3 - $30.64 $1.93 Million - $3.63 Million
-118,312 Reduced 88.62%
15,200 $466,000
Q2 2020

Aug 14, 2020

SELL
$7.95 - $18.81 $256,451 - $606,772
-32,258 Reduced 19.46%
133,512 $2.18 Million
Q1 2020

May 15, 2020

SELL
$6.45 - $14.04 $94,511 - $205,728
-14,653 Reduced 8.12%
165,770 $1.65 Million
Q4 2019

Feb 14, 2020

BUY
$12.97 - $15.94 $1.51 Million - $1.86 Million
116,777 Added 183.48%
180,423 $2.48 Million
Q3 2019

Nov 14, 2019

SELL
$14.75 - $20.87 $343,026 - $485,352
-23,256 Reduced 26.76%
63,646 $966,000
Q2 2019

Aug 14, 2019

BUY
$14.71 - $19.79 $275,474 - $370,607
18,727 Added 27.47%
86,902 $1.71 Million
Q1 2019

May 15, 2019

BUY
$13.73 - $16.87 $936,042 - $1.15 Million
68,175 New
68,175 $1.13 Million
Q4 2018

Feb 14, 2019

SELL
$10.6 - $17.49 $201,686 - $332,782
-19,027 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$16.65 - $21.85 $316,799 - $415,739
19,027 New
19,027 $333,000
Q2 2018

Aug 14, 2018

SELL
$14.8 - $18.8 $573,411 - $728,387
-38,744 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$14.5 - $23.4 $561,788 - $906,609
38,744 New
38,744 $726,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $747M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.